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Abstract:  
Focal Points 
 Patient outcome data for individual MI centres could be a powerful QA tool. 
 It is feasible to collect such data for both professional & patient enquiries. 
 Subject to validation, this approach to QA could be easily rolled out nationally. 
 
Introduction 
In recent years, the effects of Medicines Information (MI) services on patient outcome 
have become a focus for research. Positive effects of an MI enquiry answering service for 
healthcare professionals (HCPs) have been demonstrated & small scale projects have 
found similar benefits for patient helplines. If patient outcome data could be collected 
through routine MI quality assurance programmes, they might provide a powerful tool for 
monitoring the quality & worth of an individual MI service. 
 
Method 
Two key patient outcome questions for HCP enquiries were validated in a recent national 
study: how did the advice from MI affect your patient’s care or outcome? &, how did the 
advice from MI affect the safety of your patient’s drug therapy? These questions were 
added to the standard national user survey for the MI centre at the RUH, Bath. In other 
regards, the user survey remained unchanged for the next 15 months. 
 
When the same centre opened a patient helpline, there was no equivalent validated tool to 
measure patient outcomes for the new service. Therefore, a simple survey was devised & 
distributed by post (including a paid return envelope) to every caller for the first 6 months 
of helpline operation & subsequently to two randomly selected callers each week. 
 
Results 
The HCP survey response rate for the two years prior to the introduction of patient 
outcome questions was 78%. This fell to 68% in the first 15 months after the introduction 
of patient outcome questions. Over this time, 61% of respondents answered the patient 
outcome questions. 86 responses to the outcome questions were received over the first 
2.5 years. A positive impact on patient care or outcome was reported for 90% of patients, 
with 17% of patients experiencing improved outcome. A positive impact on medicines 
safety was reported for 87% of patients, with 22% of patients avoiding a major risk. These 
figures are comparable with data from the original national study. 
 
A response rate of 49% was achieved for the patient helpline survey, giving data from 
29% of callers. 100% of responders stated that they found the advice they received helpful 
& that they followed it. 98% of responders stated that calling the helpline had improved 
their experience of the hospital. The following patient benefits were reported: medicines 
problem solved or avoided (74%), reassurance (38%), patient changed how they take 
their medicines (19%) & a change was made to a prescription (13%). Patients reported 
that calling the helpline had increased their understanding of interactions (31%), side 
effects (17%), safety (17%) & dosage (15%). Respondents stated that if they had not been 
able to phone the helpline, they would have contacted their GP surgery (65%), community 
pharmacy (40%), someone else at the hospital (31%), NHS Direct/111 (10%) or searched 
the internet (10%). A medication error was identified and corrected following 19% of calls. 
 
Discussion 
Questions regarding patient outcome can be included in regular MI user surveys whilst still 
achieving good response rates. The data obtained can be used to ensure the MI centre in 
question is working to a high standard & to demonstrate the patient value obtained from 
the provision of the service. HCP enquiry patient outcome questions have already been 
validated & could be quickly incorporated into the national MI user survey. Further 
research is required to validate patient helpline outcome questions. This should be a high 
priority for future research. 
  
 
